High Strength Steel Market Research Report- Forecast to 2023

High Strength Steel Market Research Report- Forecast to 2023

ID: MRFR/CnM/4183-HCRR | September, 2018 | Region: Global | 139 pages | Half-Cooked Research Reports

Global High Strength Steel Market Research Report: By Product Type (High Strength Low Alloy Steel, Dual Phase Steel, Hardenable Brake Steel, Carbon Manganese Steel And Others), And End Use (Automotive, Construction) – Forecast Till 2023


Synopsis of High strength steel Market:


Steel is an alloy of carbon, iron, and other elements, which is extensively used in the infrastructure, buildings, machinery, ships, automobiles, and weapons among others. High strength steels are a class of steel that possesses better chemical and mechanical properties. These high strength has better resistance to corrosion & chemicals and is manufactured to meet specific mechanical properties, unlike normal carbon steel.  High strength steel has a carbon content of around 0.05 to 0.25 %, and other alloys include manganese (around 2%), copper, niobium, nickel, and others. These high strength steel are used in applications such as trucks, cranes, roller coasters, and other infrastructures, which requires specific strength to weight ration. The major end-use industries include automotive, building & construction, military & defense, mining & other manufacturing units. However, high production cost coupled with the safety and technological constraints are some of the major downsides to the growth of the market.


The growing infrastructural developments across the globe along with the growing adoption in the automobile sector is the key factor driving the growth of the global high strength market.  Moreover, the growing purchasing power in the developing regions has augmented the sale of automobiles, which, in turn, is expected to substantially contribute to the growth of the high strength steel market. Growing defense budget has further boosted the demand for high strength steel in the military equipment owing to its enhanced fatigue, corrosion, and impact resistance.


Among the various product segments in high strength steel market, high strength low alloy steel is leading and is anticipated to continue dominating over the forecast period.  The properties such as ductile, easy to weld, and formable has augmented the use of these steel in the automobile industry.


Global High strength steel Market Share, by End-Use Industry


High strength steel Market 
Source: MRFR analysis


Regional Analysis 


The high strength steel market is segmented into five regions: Europe, Latin America, Asia Pacific, North America, and the Middle East & Africa. Among these, Asia Pacific is the leading region in the market and is expected to exhibit an expanding CAGR during the forecast period. Growing development of industries in the developing economies such as China and India are primarily driving the growth of the high strength steel market. Moreover, the developing automobile industry in the region is expected to have a positive impact on the growth of the high strength steel market. The growing infrastructural development, especially in China, is anticipated to further propel the demand for high strength steel in the region.


North America is a dominant region in the global market and is anticipated to retain its dominance during the assessed years. The developed end-use industries coupled with the growing technological advancement in the region is the key factor attributing to this growth. Moreover, the presence of the major automobile manufacturers in the region has further boosted the market demand for high strength steel.  Europe is another significant market due to the well-developed automobile industry. Moreover, the implementation of emission standards such as Euro 5 and Euro 6 is expected to push the growth of the high strength steel market further in the region. High strength steel helps in reducing the weight of automobile, which, in turn, add to the minimization of vehicle emissions.


Segmental Analysis


The global high strength steel market is segmented into product type and end-user industry. On the basis of the product type, the market is segregated into high strength low alloy steel, dual phase steel, hardenable brake steel, carbon manganese steel, and others. On the basis of the end-user industry, the global market can be further segmented into automotive, building & construction, mining & other equipment, aviation, marine, military & defense, and others.


Key Players


Some of the prominent players operating in the global high strength steel market are Arcelor Mittal (Luxembourg), United States Steel Corporation (U.S.), Voestalpine AG (Austria), SSAB (Sweden), Shandong Steel Group (China), SAIL (India), Tata Steels (India), Nippon Steel and Sumitomo Metal Corporation (Japan), POSCO (South Korea), Wuhan Iron and Steel Corporation (China), Tata Steels Limited (India) and Nippon Steel & Sumitomo Metal Corporation (Japan) among others.


Geographical Analysis


The report covers brief analysis of the major geographic regions namely Asia Pacific, Europe, North America, Latin America, and the Middle East & Africa.


Intended Audience



  • High strength steel  market manufacturers

  • Traders and Distributors of High strength steel market

  • Production process industries

  • Potential investors

  • Raw material suppliers

  • Nationalized laboratory 

TABLE OF CONTENT



Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Healthcare Contract Manufacturing Market, by Product

6.1 Introduction

6.2 Active Pharmaceutical Ingredients (API)

6.2.1 Market Estimates & Forecast, 2016 – 2023

6.3 Dosage Formulations (FDF)

6.3.1 Market Estimates & Forecast, 2016 – 2023

6.3.2 Tablet

6.3.2.1 Market Estimates & Forecast, 2017 – 2023

6.3.3 Capsule

6.3.3.1 Market Estimates & Forecast, 2017 – 2023

6.3.4 Oral Liquids

6.3.4.1 Market Estimates & Forecast, 2017 – 2023

6.3.5 Parenteral/Injectables

6.3.5.1 Market Estimates & Forecast, 2017 – 2023

6.3.6 Others

6.4 Advanced Drug Delivery Products

6.4.1 Market Estimates & Forecast, 2016 – 2023

6.5 OTC Medicines and Nutritional Products

6.5.1 Market Estimates & Forecast, 2016 – 2023

6.6 Others

Chapter 7. Global Healthcare Contract Manufacturing Market, by Industry

7.1 Introduction

7.2 Pharmaceutical

7.2.1 Market Estimates & Forecast, 2017 – 2023

7.3 Biopharmaceutical

7.3.1 Market Estimates & Forecast, 2017 – 2023

7.4 Others

Chapter 8. Global Healthcare Contract Manufacturing Market, by Type

8.1 Introduction

8.2 Sterile

8.2.1 Market Estimates & Forecast, 2017 – 2023

8.3 Non-Sterile

8.3.1 Market Estimates & Forecast, 2017 – 2023

8.4 Others

Chapter 9. Global Healthcare Contract Manufacturing Market, by Service

9.1 Introduction

9.2 Oncology Research

9.2.1 Market Estimates & Forecast, 2017 – 2023

9.3 Vaccines Research

9.3.1 Market Estimates & Forecast, 2017 – 2023

9.4 Inflammation & Immunology Research

9.4.1 Market Estimates & Forecast, 2017 – 2023

9.5 Cardiology Research

9.5.1 Market Estimates & Forecast, 2017 – 2023

9.6 Neuroscience Research

9.6.1 Market Estimates & Forecast, 2017 – 2023

9.7 Others

Chapter. 10 Global Healthcare Contract Manufacturing Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Rest of the The Middle East & Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Patheon

12.1.1 Company Overview

12.1.2 Type Overview

12.1.3 Financials

12.1.4 Key Developments

12.2 Catalent

12.2.1 Company Overview

12.2.2 Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.3 Lonza

12.3.1 Company Overview

12.3.2 Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.4 Evonik Industries

12.4.1 Company Overview

12.4.2 Type/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Boehringer Ingelheim Bioxcellence

12.5.1 Company Overview

12.5.2 Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Famar S.A.

12.6.1 Company Overview

12.6.2 Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Fareva Group

12.7.1 Overview

12.7.2 Type Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Vetter Pharma International

12.8.1 Company Overview

12.8.2 Type/Business Segment Overview

12.8.3 Financial Overview

12.8.4 Key Development

12.8.5 SWOT Analysis

12.9 Mylan

12.9.1 Company Overview

12.9.2 Type Overview

12.9.3 Financial overview

12.9.4 Key Developments

12.10 Recipharm

12.10.1 Company Overview

12.10.2 Type/Business Segment Overview

12.10.3 Financial Overview

12.10.4 Key Development

12.10.5 SWOT Analysis

12.11 Aesica Pharmaceuticals

12.11.1 Company Overview

12.11.2 Type Overview

12.11.3 Financial overview

12.11.4 Key Developments

12.12 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical industry

Chapter 14 Appendix



LIST OF TABLES



Table 1 Healthcare contract manufacturing Industry Synopsis, 2017 – 2023

Table 2 Healthcare contract manufacturing Market Estimates and Forecast, 2017 – 2023, (USD Million)

Table 3 Healthcare contract manufacturing Market by Region, 2017 – 2023, (USD Million)

Table 4 Healthcare contract manufacturing Market by Product, 2017 – 2023, (USD Million)

Table 5 Healthcare contract manufacturing Market by Industry, 2017 – 2023, (USD Million)

Table 6 Healthcare contract manufacturing Market by Type, 2017 – 2023, (USD Million)

Table 7 Healthcare contract manufacturing Market by Service, 2017 – 2023, (USD Million)

Table 8 North America Healthcare contract manufacturing Market by Product, 2017 – 2023, (USD Million)

Table 9 North America Healthcare contract manufacturing Market by Industry, 2017 – 2023, (USD Million)

Table 10 North America Healthcare contract manufacturing Market by Type, 2017 – 2023, (USD Million)

Table 11 North America Healthcare contract manufacturing Market by Services, 2017 – 2023, (USD Million)

Table 12 US Healthcare contract manufacturing Market by Product, 2017 – 2023, (USD Million)

Table 13 US Healthcare contract manufacturing Market by Industry, 2017 – 2023, (USD Million)

Table 14 US Healthcare contract manufacturing Market by Type, 2017 – 2023, (USD Million)

Table 15 US Healthcare contract manufacturing Market by Services, 2017 – 2023, (USD Million)

Table 16 Canada Healthcare contract manufacturing Market by Product, 2017 – 2023, (USD Million)

Table 17 Canada Healthcare contract manufacturing Market by Industry, 2017 – 2023, (USD Million)

Table 18 Canada Healthcare contract manufacturing Market by Type, 2017 – 2023, (USD Million)

Table 19 Canada Healthcare contract manufacturing Market by Services, 2017 – 2023, (USD Million)

Table 20 South America Healthcare contract manufacturing Market by Product, 2017 – 2023, (USD Million)

Table 21 South America Healthcare contract manufacturing Market by Industry, 2017 – 2023, (USD Million)

Table 22 South America Healthcare contract manufacturing Market by Type, 2017 – 2023, (USD Million)

Table 23 South America Healthcare contract manufacturing Market by Services, 2017 – 2023, (USD Million)

Table 24 Europe Healthcare contract manufacturing Market by Product, 2017 – 2023, (USD Million)

Table 25 Europe Healthcare contract manufacturing Market by Industry, 2017 – 2023, (USD Million)

Table 26 Europe Healthcare contract manufacturing Market by Type, 2017 – 2023, (USD Million)

Table 27 Europe Healthcare contract manufacturing Market by Services, 2017 – 2023, (USD Million)

Table 28 Western Europe Healthcare contract manufacturing Market by Product, 2017 – 2023, (USD Million)

Table 29 Western Europe Healthcare contract manufacturing Market by Industry, 2017 – 2023, (USD Million)

Table 30 Western Europe Healthcare contract manufacturing Market by Type, 2017 – 2023, (USD Million)

Table 31 Western Europe Healthcare contract manufacturing Market by Services, 2017 – 2023, (USD Million)

Table 32 Eastern Europe Healthcare contract manufacturing Market by Product, 2017 – 2023, (USD Million)

Table 33 Eastern Europe Healthcare contract manufacturing Market by Industry, 2017 – 2023, (USD Million)

Table 34 Eastern Europe Healthcare contract manufacturing Market by Type, 2017 – 2023, (USD Million)

Table 35 Eastern Europe Healthcare contract manufacturing Market by Services, 2017 – 2023, (USD Million)

Table 36 Asia Pacific Healthcare contract manufacturing Market by Product, 2017 – 2023, (USD Million)

Table 37 Asia Pacific Healthcare contract manufacturing Market by Industry, 2017 – 2023, (USD Million)

Table 38 Asia Pacific Healthcare contract manufacturing Market by Type, 2017 – 2023, (USD Million)

Table 39 Asia Pacific Healthcare contract manufacturing Market by Services, 2017 – 2023, (USD Million)

Table 40 The Middle East & Africa Healthcare contract manufacturing Market by Product, 2017 – 2023, (USD Million)

Table 41 The Middle East & Africa Healthcare contract manufacturing Market by Industry, 2017 – 2023, (USD Million)

Table 42 The Middle East & Africa Healthcare contract manufacturing Market by Type, 2017 – 2023, (USD Million)

Table 43 The Middle East & Africa Healthcare contract manufacturing Market by Services, 2017 – 2023, (USD Million)



LIST OF FIGURES





Figure 1 Research Process

Figure 2 Segmentation for Healthcare contract manufacturing Market

Figure 3 Segmentation Market Dynamics for Healthcare contract manufacturing Market

Figure 4 Global Healthcare contract manufacturing Market Share, by Product 2016

Figure 5 Global Healthcare contract manufacturing Market Share, by Industry 2016

Figure 6 Global Healthcare contract manufacturing Market Share, by Type, 2016

Figure 8 Global Healthcare contract manufacturing Market Share, by Technology, 2016

Figure 9 Global Healthcare contract manufacturing Market Share, by Service, 2016

Figure 10 Global Healthcare contract manufacturing Market Share, by Region, 2016

Figure 11 North America Healthcare contract manufacturing Market Share, by Country, 2016

Figure 12 Europe Healthcare contract manufacturing Market Share, by Country, 2016

Figure 13 Asia Pacific Healthcare contract manufacturing Market Share, by Country, 2016

Figure 14 The Middle East & Africa Healthcare contract manufacturing Market Share, by Country, 2016

Figure 15 Global Healthcare contract manufacturing Market: Company Share Analysis, 2016 (%)

Figure 16 Patheon: Key Financials

Figure 17 Patheon: Segmental Revenue

Figure 18 Patheon: Geographical Revenue

Figure 19 Catalent: Key Financials

Figure 20 Catalent: Segmental Revenue

Figure 21 Catalent: Geographical Revenue

Figure 22 Lonza: Key Financials

Figure 23 Lonza: Segmental Revenue

Figure 24 Lonza: Geographical Revenue

Figure 25 Evonik Industries: Key Financials

Figure 26 Evonik Industries: Segmental Revenue

Figure 27 Evonik Industries: Geographical Revenue

Figure 28 Boehringer Ingelheim Bioxcellence: Key Financials

Figure 29 Boehringer Ingelheim Bioxcellence: Segmental Revenue

Figure 30 Boehringer Ingelheim Bioxcellence: Geographical Revenue

Figure 32 Famar S.A.: Key Financials

Figure 33 Famar S.A.: Segmental Revenue

Figure 34 Famar S.A.: Geographical Revenue

Figure 35 Fareva Group: Key Financials

Figure 36 Fareva Group: Segmental Revenue

Figure 37 Fareva Group: Geographical Revenue

Figure 38 Vetter Pharma International: Key Financials

Figure 39 Vetter Pharma International: Segmental Revenue

Figure 40 Vetter Pharma International: Geographical Revenue

Figure 41 Mylan: Key Financials

Figure 42 Mylan: Segmental Revenue

Figure 43 Mylan: Geographical Revenue